Redwood Investments LLC raised its position in shares of UnitedHealth Group Inc. (NYSE:UNH) by 10.6% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 191,023 shares of the healthcare conglomerate’s stock after buying an additional 18,324 shares during the period. UnitedHealth Group makes up 2.5% of Redwood Investments LLC’s holdings, making the stock its 4th largest position. Redwood Investments LLC’s holdings in UnitedHealth Group were worth $26,972,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also made changes to their positions in UNH. Bank of Montreal Can acquired a new position in shares of UnitedHealth Group during the second quarter worth about $207,013,000. Dodge & Cox increased its position in shares of UnitedHealth Group by 9.6% in the first quarter. Dodge & Cox now owns 15,183,189 shares of the healthcare conglomerate’s stock worth $1,957,113,000 after buying an additional 1,324,136 shares during the period. Prudential Financial Inc. increased its position in shares of UnitedHealth Group by 47.4% in the first quarter. Prudential Financial Inc. now owns 2,458,710 shares of the healthcare conglomerate’s stock worth $316,927,000 after buying an additional 790,220 shares during the period. NN Investment Partners Holdings N.V. acquired a new position in shares of UnitedHealth Group during the first quarter worth about $83,434,000. Finally, UBS Asset Management Americas Inc. increased its position in shares of UnitedHealth Group by 13.0% in the first quarter. UBS Asset Management Americas Inc. now owns 4,424,657 shares of the healthcare conglomerate’s stock worth $570,338,000 after buying an additional 508,995 shares during the period. Hedge funds and other institutional investors own 85.78% of the company’s stock.
Shares of UnitedHealth Group Inc. (NYSE:UNH) traded up 0.14% during midday trading on Friday, hitting $136.66. The stock had a trading volume of 2,568,703 shares. The company’s 50 day moving average is $137.92 and its 200 day moving average is $136.28. The company has a market cap of $130.15 billion, a PE ratio of 21.39 and a beta of 0.57. UnitedHealth Group Inc. has a 52-week low of $107.51 and a 52-week high of $144.48.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 19th. The healthcare conglomerate reported $1.96 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.89 by $0.07. UnitedHealth Group had a return on equity of 19.08% and a net margin of 3.51%. The business had revenue of $46.50 billion for the quarter, compared to the consensus estimate of $45.05 billion. On average, analysts anticipate that UnitedHealth Group Inc. will post $7.90 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 20th. Stockholders of record on Friday, September 9th were given a $0.625 dividend. The ex-dividend date of this dividend was Tuesday, September 6th. This represents a $2.50 annualized dividend and a dividend yield of 1.83%. UnitedHealth Group’s payout ratio is 39.12%.
A number of research analysts have issued reports on UNH shares. Leerink Swann restated an “outperform” rating on shares of UnitedHealth Group in a research note on Sunday, August 21st. Sanford C. Bernstein reiterated an “outperform” rating and set a $178.00 price target on shares of UnitedHealth Group in a research note on Tuesday, September 6th. Royal Bank Of Canada increased their price target on UnitedHealth Group from $157.00 to $165.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 20th. Credit Suisse Group AG reiterated a “buy” rating and set a $148.00 price target on shares of UnitedHealth Group in a research note on Wednesday, June 29th. Finally, Zacks Investment Research downgraded UnitedHealth Group from a “hold” rating to a “sell” rating in a research note on Monday, July 18th. One investment analyst has rated the stock with a hold rating, twenty-four have assigned a buy rating and one has assigned a strong buy rating to the company. UnitedHealth Group presently has a consensus rating of “Buy” and a consensus target price of $155.35.
In other news, Director Richard T. Burke sold 40,000 shares of the business’s stock in a transaction dated Wednesday, September 7th. The stock was sold at an average price of $135.31, for a total value of $5,412,400.00. Following the transaction, the director now directly owns 2,003,550 shares in the company, valued at $271,100,350.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 1.65% of the stock is owned by insiders.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc. (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.